Rieche K
Arch Geschwulstforsch. 1976;46(3):225-9.
There are some impacts in tumour chemotherapy being worth-while to be discussed. Considering the information received during the Ninth International Congress of Chemotherapy, held in 1975, the author tries to evaluate the present state of clinical tumour chemotherapy from clinical point of view. The modern oncological clinician (oncologist) has to be faced with a lot of new facts, e.g. use of quantitative differences between normal and tumour cells for individualization of therapy, timing of cancer drug administration, new drugs for cancer treatment, mutual inhibition or potentiation of drug's effects, immunotherapy and possible adverse effects of clinically available drugs.
肿瘤化疗存在一些值得探讨的影响。根据1975年召开的第九届国际化疗大会所获得的信息,作者试图从临床角度评估临床肿瘤化疗的现状。现代肿瘤临床医生(肿瘤学家)必须面对许多新情况,例如利用正常细胞与肿瘤细胞之间的定量差异进行个体化治疗、癌症药物给药的时机、用于癌症治疗的新药、药物作用的相互抑制或增强、免疫疗法以及临床可用药物可能产生的不良反应。